Hartford Investment Management Co. decreased its position in Waters Co. (NYSE:WAT) by 2.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,452 shares of the medical instruments supplier’s stock after selling 210 shares during the quarter. Hartford Investment Management Co.’s holdings in Waters were worth $1,594,000 at the end of the most recent quarter.
A number of other large investors have also recently modified their holdings of the stock. Bank of New York Mellon Corp grew its stake in shares of Waters by 156.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 4,358,976 shares of the medical instruments supplier’s stock worth $843,852,000 after buying an additional 2,657,055 shares in the last quarter. State of Alaska Department of Revenue grew its stake in shares of Waters by 6.6% in the 3rd quarter. State of Alaska Department of Revenue now owns 15,715 shares of the medical instruments supplier’s stock worth $3,057,000 after buying an additional 969 shares in the last quarter. DNB Asset Management AS grew its stake in shares of Waters by 11.1% in the 3rd quarter. DNB Asset Management AS now owns 13,309 shares of the medical instruments supplier’s stock worth $2,591,000 after buying an additional 1,326 shares in the last quarter. Clinton Group Inc. purchased a new position in shares of Waters in the 3rd quarter worth $219,000. Finally, First Hawaiian Bank purchased a new position in shares of Waters in the 3rd quarter worth $208,000. 96.14% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities analysts recently commented on the stock. Zacks Investment Research raised shares of Waters from a “hold” rating to a “buy” rating and set a $256.00 price target for the company in a research note on Wednesday, January 30th. Goldman Sachs Group cut shares of Waters from a “neutral” rating to a “sell” rating and dropped their price target for the stock from $185.00 to $180.00 in a research note on Friday, November 30th. TheStreet lowered shares of Waters from a “b” rating to a “c+” rating in a report on Thursday, December 20th. BTIG Research boosted their price objective on shares of Waters to $260.00 and gave the stock a “buy” rating in a research note on Thursday, January 24th. Finally, UBS Group reduced their price objective on shares of Waters from $210.00 to $200.00 and set a “neutral” rating for the company in a research note on Wednesday, October 24th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have given a buy rating to the company. Waters presently has an average rating of “Hold” and a consensus target price of $208.99.
NYSE:WAT opened at $231.00 on Monday. The company has a market cap of $17.50 billion, a price-to-earnings ratio of 27.86, a P/E/G ratio of 2.28 and a beta of 1.17. Waters Co. has a twelve month low of $167.93 and a twelve month high of $233.48. The company has a current ratio of 2.26, a quick ratio of 2.01 and a debt-to-equity ratio of 0.61.
Waters (NYSE:WAT) last released its earnings results on Wednesday, January 23rd. The medical instruments supplier reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.64 by $0.23. The company had revenue of $715.00 million for the quarter, compared to the consensus estimate of $702.74 million. Waters had a net margin of 24.54% and a return on equity of 34.18%. Waters’s revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.51 EPS. On average, equities research analysts expect that Waters Co. will post 9.35 earnings per share for the current year.
In other news, SVP Elizabeth B. Rae sold 10,800 shares of the company’s stock in a transaction on Tuesday, February 5th. The shares were sold at an average price of $232.35, for a total value of $2,509,380.00. Following the sale, the senior vice president now directly owns 8,794 shares of the company’s stock, valued at approximately $2,043,285.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Christopher A. Kuebler sold 8,000 shares of the company’s stock in a transaction on Friday, November 16th. The shares were sold at an average price of $199.67, for a total transaction of $1,597,360.00. Following the completion of the sale, the director now directly owns 18,911 shares in the company, valued at $3,775,959.37. The disclosure for this sale can be found here. In the last three months, insiders have sold 97,249 shares of company stock worth $20,981,857. 0.98% of the stock is owned by insiders.
COPYRIGHT VIOLATION WARNING: This story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2019/02/11/hartford-investment-management-co-sells-210-shares-of-waters-co-wat.html.
Waters Company Profile
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Article: What are the risks of holding treasury bonds?
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.